Pre-earnings options volume in Lexicon (LXRX) Pharmaceuticals is normal with calls leading puts 16:1. Implied volatility suggests the market is anticipating a move near 25.9%, or 17c, after results are released. Median move over the past eight quarters is 7.5%.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXRX:
- Largest borrow rate increases among liquid names
- LXRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Biotech Alert: Searches spiking for these stocks today
- Lexicon Pharmaceuticals: Strategic Partnerships and Pipeline Advancements Drive Buy Rating
- Lexicon announces exclusive license agreement with Novo Nordisk for LX9851